Response to A+CHP by CD30 expression in the ECHELON-2 trial.

Abstract Poster

Authors

null

Ranjana H. Advani

Stanford Cancer Institute, Stanford, CA

Ranjana H. Advani , Steven M. Horwitz , Swaminathan Padmanabhan Iyer , Nancy L. Bartlett , Won Seog Kim , Herve Tilly , David Belada , Tatyana Feldman , Árpád Illés , Eric D. Jacobsen , Andreas Huettmann , Pier Luigi Zinzani , Owen A. O'Connor , William L. Trepicchio , Harry H. Miao , Shangbang Rao , Matthew Onsum , Thomas John Manley , Tim Illidge

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01777152

Citation

J Clin Oncol 37, 2019 (suppl; abstr 7538)

DOI

10.1200/JCO.2019.37.15_suppl.7538

Abstract #

7538

Poster Bd #

292

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Annual Meeting

Neurofilament light chains: A biomarker for vincristine-related neuropathy.

Neurofilament light chains: A biomarker for vincristine-related neuropathy.

First Author: Gretchen A McNally

First Author: Raphael Eric Steiner

First Author: Hua-Jay Jeffery Cherng

First Author: Mariano Provencio-Pulla